Organigram Revenue and Competitors
Estimated Revenue & Valuation
- Organigram's estimated annual revenue is currently $90.2M per year. 0
- Organigram's total funding is $528.3M.
- Organigram's current valuation is $513.5M. (January 2022)
Employee Data
- 00
Organigram's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Sales | Reveal Email/Phone |
3 | VP Finance & Accounting | Reveal Email/Phone |
4 | SVP, Operations | Reveal Email/Phone |
5 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
6 | Director, Board Directors | Reveal Email/Phone |
7 | Director Quality Assurance, QAP | Reveal Email/Phone |
8 | Senior Director Maintenance and Engineering | Reveal Email/Phone |
9 | Director Safety & Security & Maintenance | Reveal Email/Phone |
10 | Senior Brand Manager | Reveal Email/Phone |
Organigram Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $90.2M | 0 | N/A | $528.3M | N/A |
#2 | $52.3M | 176 | 9% | N/A | N/A |
What Is Organigram?
Strong roots. At Organigram, it's a concept that matters. Organigram Inc. (TSX-V:OGI) is Atlantic Canada's original licensed producer of high-quality medical cannabis. Founded in 2013 and the 13th licensed applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations, formerly Marihuana for Medical Purposes Regulations), Organigram is committed to producing dried cannabis flower and extract oils of the highest standard and providing relief to patients across the country. For more information on Organigram's products, investor relations, or for information on becoming a patient, visit WWW.ORGANIGRAM.CA or call 1-855-961-9420.
keywords:N/A
$528.3M
Total Funding
N/A
Number of Employees
$90.2M
Revenue (est)
N/A
Employee Growth %
$513.5M
Valuation
N/A
Accelerator
Organigram News
Canadian cannabis company Organigram Holdings ( OGI -3.80% ) reported its second-quarter fiscal 2022 earnings today, and investors liked...
(together, the Company or Organigram), a leading licensed producer of cannabis, announced its results for the second quarter ended February...
Organigram Reports Second Quarter Fiscal 2022 Results. Achieves positive Adjusted EBITDA two quarters earlier than expected driven by record...
Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer
The stock in question is OrganiGram Holdings (NASDAQOTH:OGRMF). Had you bought OrganiGram in early 2016 and held on, you'd now be
Other Companies in Moncton
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.5M | 11 | 0% | N/A |
#2 | $1.8M | 12 | -45% | N/A |
#3 | $2.8M | 13 | 0% | N/A |
#4 | $1.2M | 14 | 0% | N/A |
#5 | $1.2M | 15 | -6% | N/A |